Capital Change Notice

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Oceania Healthcare Limited (Oceania) to OCA Employees Trustee Limited (Trustee), which will hold the shares on trust for every eligible employee of Oceania (full-time and part-time) who has elected to participate in Oceania's Employee Share Scheme in 2023 (Participating Employee). Those shares will be subject to a restrictive period that applies under the terms of the Employee Share Scheme Trust Deed (Restrictive Period). Upon expiry of the Restrictive Period, the legal interest in those shares will be transferred from the Trustee to the Participating Employees. Section 1: Issuer information Name of issuer Oceania Healthcare Limited NZX ticker code OCA Class of financial product Ordinary Shares ISIN (If unknown, check on NZX website) NZOCAE0002SO Currency NZD Section 2: Capital change details Number issued 53,761 ordinary shares issued Nominal value (if any) N/A Issue price per security No consideration is payable for the issue of the shares Nature of the payment (for example, cash or other consideration) N/A Amount paid up (if not in full) Fully paid Percentage of total class of Financial Products issued (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 0.0074% For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) N/A Reason for issue and specific authority for issue (the reason for change must be identified here) Issue of ordinary shares to satisfy requirements under the 2023 invitation of Oceania's Employee Share Scheme. Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 724,154,779 ordinary shares after the issue. In the case of an acquisition of shares, whether those shares are to be held as treasury stock N/A Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue is made Directors' resolution dated 25 August 2023 and NZX Listing Rule 4.6.1. Terms or details of the issue (for example: restrictions, escrow arrangements) The terms of the issue of the shares are: (1) the beneficial interest in $800 of ordinary shares in Oceania (for full-time Participating Employees) or $400 (for part-time Participating Employees) of ordinary shares in Oceania will be allocated to Participating Employees; (2) the number of shares a Participating Employee receives a beneficial interest in will be determined by reference to the volume weighted average price of Oceania's Ordinary Shares on the NZX Main Board during the five business days before the day before the allocation date (being 25 September 2023; (3) there will be no cost to the Participating Employees to acquire the shares; and (4) there will be no restrictions on the shares once the legal interest in those shares have been transferred to Participating Employees at the end of the Restrictive Period. Date of issue 25/09/2023 Section 3: Authority for this announcement and contact person Name of person authorised to make this announcement Anna Thorburn Contact person for this announcement Anna Thorburn Contact phone number 09 361 0350 Contact email address anna.thorburn@oceaniahealthcare.co.nz Date of release through MAP 26/09/2023 End CA:00418896 For:OCA Type:SECISSUE Time:2023-09-26 14:06:51